0001493152-23-002085.txt : 20230120
0001493152-23-002085.hdr.sgml : 20230120
20230120200013
ACCESSION NUMBER: 0001493152-23-002085
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230118
FILED AS OF DATE: 20230120
DATE AS OF CHANGE: 20230120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leon Francisco
CENTRAL INDEX KEY: 0001728920
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38552
FILM NUMBER: 23542304
MAIL ADDRESS:
STREET 1: C/O PROVENTION BIO, INC.
STREET 2: 110 OLD DRIFTWAY LANE
CITY: LEBANON
STATE: NJ
ZIP: 08833
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Provention Bio, Inc.
CENTRAL INDEX KEY: 0001695357
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 55 BROAD STREET, 2ND FLOOR
CITY: RED BANK
STATE: NJ
ZIP: 07701
BUSINESS PHONE: 908-428-9136
MAIL ADDRESS:
STREET 1: 55 BROAD STREET, 2ND FLOOR
CITY: RED BANK
STATE: NJ
ZIP: 07701
FORMER COMPANY:
FORMER CONFORMED NAME: Provention Inc.
DATE OF NAME CHANGE: 20170120
4
1
ownership.xml
X0306
4
2023-01-18
0
0001695357
Provention Bio, Inc.
PRVB
0001728920
Leon Francisco
C/O PROVENTION BIO, INC.
55 BROAD STREET, 2ND FLOOR
RED BANK
NJ
07701
0
1
0
0
Chief Scientific Officer
Common Stock
2023-01-18
4
M
0
24015
2.5
A
1597015
D
Common Stock
2023-01-18
4
S
0
24015
10.2679
D
1573000
D
Common Stock
1000000
I
By Trust
Stock Option (right to buy)
2.5
2023-01-18
4
M
0
24015
0
D
2027-04-25
Common Stock
24015
318088
D
The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2022.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.13 to $10.41 per share, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
The option is fully vested.
/s/ Thierry Chauche, as attorney-in-fact
2023-01-20